Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S T Frequin

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
AJR. American Journal of Roentgenology|November 1, 1992
Relapsing-remitting multiple sclerosis: sequential enhanced MR imaging vs clinical findings in determining disease activityF Barkhof, P Scheltens, S T Frequin, et al.
Neurology|January 1, 1992
A correlative triad of gadolinium-DTPA MRI, EDSS, and CSF-MBP in relapsing multiple sclerosis patients treated with high-dose intravenous methylprednisoloneF Barkhof, S T Frequin, O R Hommes, et al.
Neuroradiology|July 1, 1994
Limited duration of the effect of methylprednisolone on changes on MRI in multiple sclerosisF Barkhof, M W Tas, S T Frequin, et al.
Neurology|September 1, 1995
Correlating MRI and clinical disease activity in multiple sclerosis: relevance of hypointense lesions on short-TR/short-TE (T1-weighted) spin-echo imagesM A van Walderveen, F Barkhof, O R Hommes, et al.
Neurology|February 1, 1994
Magnetic resonance evaluation of disease activity during pregnancy in multiple sclerosisM A van Walderveen, M W Tas, F Barkhof, et al.
European Neurology|August 7, 1998
Patterns of brain magnetic resonance abnormalities on T2-weighted spin echo images in clinical subgroups of multiple sclerosis: a large cross-sectional studyM A van Walderveen, F Barkhof, M W Tas, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 1, 1997
Specific power calculations for magnetic resonance imaging (MRI) in monitoring active relapsing-remitting multiple sclerosis (MS): implications for phase II therapeutic trialsL Truyen, F Barkhof, M Tas, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
AJR. American Journal of Roentgenology|November 1, 1992
Relapsing-remitting multiple sclerosis: sequential enhanced MR imaging vs clinical findings in determining disease activityF Barkhof, P Scheltens, S T Frequin, et al.
Neurology|January 1, 1992
A correlative triad of gadolinium-DTPA MRI, EDSS, and CSF-MBP in relapsing multiple sclerosis patients treated with high-dose intravenous methylprednisoloneF Barkhof, S T Frequin, O R Hommes, et al.
Neuroradiology|July 1, 1994
Limited duration of the effect of methylprednisolone on changes on MRI in multiple sclerosisF Barkhof, M W Tas, S T Frequin, et al.
Neurology|September 1, 1995
Correlating MRI and clinical disease activity in multiple sclerosis: relevance of hypointense lesions on short-TR/short-TE (T1-weighted) spin-echo imagesM A van Walderveen, F Barkhof, O R Hommes, et al.
Neurology|February 1, 1994
Magnetic resonance evaluation of disease activity during pregnancy in multiple sclerosisM A van Walderveen, M W Tas, F Barkhof, et al.
European Neurology|August 7, 1998
Patterns of brain magnetic resonance abnormalities on T2-weighted spin echo images in clinical subgroups of multiple sclerosis: a large cross-sectional studyM A van Walderveen, F Barkhof, M W Tas, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 1, 1997
Specific power calculations for magnetic resonance imaging (MRI) in monitoring active relapsing-remitting multiple sclerosis (MS): implications for phase II therapeutic trialsL Truyen, F Barkhof, M Tas, et al.
Pageof 2